Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.
Five new and upcoming medical devices will help your patients manage their diabetes care.
Stringent control was supported even in patients at high risk for related harm. Reasons found for concern over Rx "deintensification" may surprise you.
Maintaining tight glycemic control in older diabetic adults who are in poor health can do far more harm than good, according to results of a new study.
Activation of opioid receptors with novel approaches may prevent hypoglycemia and lead to safer intensive glycemic control, according to a study reported at the American Diabetes Association 74th Scientific Sessions.
The fact that a "Diabetes Is Primary" session is held in parallel to the ADA scientific sessions is a significant recognition by the American Diabetes Association that primary care providers are the foundation of diabetes care in the United States. Highlights here.
The use of insulin has grown in recent years largely because of the widespread adoption of analogs. Out-of-pocket expenditures per prescription also increased.
Remembering the role the patient can play in preventing medication errors is important. Here I focus on potential errors resulting from nonadherence with insulin.
Patients aged 80 years or older were more than twice as likely to visit the ED and nearly 5 times as likely to be hospitalized for insulin-related hypoglycemia than those aged 45 to 64 years.
Confusion about multiple insulin products; nonadherence to the prescribed regimen; the patient’s injection technique . . . here: a look at why errors occur when insulin is prescribed—and how to prevent them.